Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study

Gynecologic Oncology

Volumn 130, Issue 3, 2013, Pages 609-614

  Puig Vives, M ^a,b,c,d   Sanchez M J ^d,e   Sanchez Cantalejo J ^e   Torrella Ramos, A ^f,g   Martos, C ^d,g   Ardanaz, E ^d,h   Chirlaque, M D ^d,i   Perucha, J ^j   Diaz J M ^k   Mateos, A ^l   MacHon M ^d,m   Marcos Gragera, R ^a,b,c,d  

^a Cancer Registry of Girona   (Spain)

^b GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^c UNIVERSITY OF GIRONA   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^f Epidemiology Unit   (Spain)

^g Center for Public Health Research   (Spain)

^h INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

ⁱ Regional Health Authority   (Spain)

^j La Rioja Cancer Registry ^*  (Spain)

^k Cuenca Cancer Registry   (Spain)

^l Health and Social Welfare Authority   (Spain)

^m Public Health Department of Gipuzkoa   (Spain)

more..

Author keywords

Breast cancer; HER2; Hormonal receptor; Molecular subtype; Relative survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; FEMALE; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR INVASION;

BREAST CANCER; HER2; HORMONAL RECEPTOR; MOLECULAR SUBTYPE; RELATIVE SURVIVAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGISTRIES; SPAIN; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84882452878     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.05.039     Document Type: Article

References (29)

1. A. Cabanes, E. Vidal, N. Aragones, B. Perez-Gomez, M. Pollan, V. Lope, and G. Lopez-Abente Cancer mortality trends in Spain: 1980-2007 Ann Oncol 21 Suppl. 3 May 2010 iii14 iii20
2. M.J. Sanchez, T. Payer, A.R. De, N. Larranaga, R. Capocaccia, and C. Martinez Cancer incidence and mortality in Spain: estimates and projections for the period 1981-2012 Ann Oncol 21 Suppl. 3 May 2010 iii30 iii36
3. O. Metzger-Filho, A. Tutt, E. de Azambuja, K.S. Saini, G. Viale, S. Loi, I. Bradbury, J.M. Bliss, H.A. Azim Jr., P. Ellis, Baselga J. Di LA, C. Sotiriou, and M. Piccart-Gebhart Dissecting the heterogeneity of triple-negative breast cancer J Clin Oncol 30 15 May 20 2012 1879 1887
4. C.M. Perou, and A.L. Borresen-Dale Systems biology and genomics of breast cancer Cold Spring Harb Perspect Biol 3 2 February 2011
5. C.M. Perou, T. Sorlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S.X. Zhu, P.E. Lonning, A.L. Borresen-Dale, P.O. Brown, and D. Botstein Molecular portraits of human breast tumours Nature 406 6797 August 17 2000 747 752
6. T. Sorlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, T. Thorsen, H. Quist, J.C. Matese, P.O. Brown, D. Botstein, P.E. Lonning, and A.L. Borresen-Dale Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 19 September 11 2001 10869 10874
7. L.A. Carey, C.M. Perou, C.A. Livasy, L.G. Dressler, D. Cowan, K. Conway, G. Karaca, M.A. Troester, C.K. Tse, S. Edmiston, S.L. Deming, J. Geradts, M.C. Cheang, T.O. Nielsen, P.G. Moorman, H.S. Earp, and R.C. Millikan Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 21 June 7 2006 2492 2502
8. M.C. Cheang, S.K. Chia, D. Voduc, D. Gao, S. Leung, J. Snider, M. Watson, S. Davies, P.S. Bernard, J.S. Parker, C.M. Perou, M.J. Ellis, and T.O. Nielsen Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst 101 10 May 20 2009 736 750
9. S. Dawood, R. Hu, M.D. Homes, L.C. Collins, S.J. Schnitt, J. Connolly, G.A. Colditz, and R.M. Tamimi Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study Breast Cancer Res Treat 126 1 February 2011 185 192
10. M. Kakarala, L. Rozek, M. Cote, S. Liyanage, and D.E. Brenner Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S. - a SEER analysis BMC Cancer 10 2010 191
11. T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J.S. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, J. Demeter, C.M. Perou, P.E. Lonning, P.O. Brown, A.L. Borresen-Dale, and D. Botstein Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci U S A 100 14 July 8 2003 8418 8423
12. A. Spitale, P. Mazzola, D. Soldini, L. Mazzucchelli, and A. Bordoni Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland Ann Oncol 20 4 April 2009 628 635
13. Y. Su, Y. Zheng, W. Zheng, K. Gu, Z. Chen, G. Li, Q. Cai, W. Lu, and X.O. Shu Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study BMC Cancer 11 2011 292
14. X.R. Yang, M.E. Sherman, D.L. Rimm, J. Lissowska, L.A. Brinton, B. Peplonska, S.M. Hewitt, W.F. Anderson, N. Szeszenia-Dabrowska, A. Bardin-Mikolajczak, W. Zatonski, R. Cartun, D. Mandich, G. Rymkiewicz, M. Ligaj, S. Lukaszek, R. Kordek, and M. Garcia-Closas Differences in risk factors for breast cancer molecular subtypes in a population-based study Cancer Epidemiol Biomarkers Prev 16 3 March 2007 439 443
15. A. Goldhirsch, W.C. Wood, A.S. Coates, R.D. Gelber, B. Thurlimann, and H.J. Senn Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 8 August 2011 1736 1747
16. A. Prat, and C.M. Perou Deconstructing the molecular portraits of breast cancer Mol Oncol 5 1 February 2011 5 23
17. M. Kaufmann, and L. Pusztai Use of standard markers and incorporation of molecular markers into breast cancer therapy: consensus recommendations from an International Expert Panel Cancer 117 8 April 15 2011 1575 1582
18. European Network of Cancer Registries, J.E. Tyczynski, E. Démaret, D.M. Parkin, World Health Organization, European Commission, and International Agency for Research on Cancer Standards and guidelines for cancer registration in Europe: the ENCR recommendations vol. I 2003 International Agency for Research on Cancer Lyon
19. O.M. Jensen, and H.H. Storm Cancer registration: principles and methods. Reporting of results IARC Sci Publ 95 1991 108 125
20. A.G. Fritz International classification of diseases for oncology: ICD-O 2000 World Health Organization Geneva
21. M.C. Martos, C. Saurina, C. Feja, M. Saez, M.C. Burriel, M.A. Barcelo, P. Gomez, G. Renart, T. Alcala, and R. Marcos-Gragera Accurately estimating breast cancer survival in Spain: cross-matching local cancer registries with the National Death Index Rev Panam Salud Publica 26 1 July 2009 51 54
22. L.H. Sobin, and C. Wittekind Union Internacional contra el Cancer. TNM: clasificaciοn de los tumores malignos: sexta ediciοn 2002 Pulso Sant Cugat del Valles
23. M. Pohar, and J. Stare Relative survival analysis in R Comput Methods Programs Biomed 81 3 March 2006 272 278
24. K. Bauer, C. Parise, and V. Caggiano Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer BMC Cancer 10 2010 228
25. A. Caldarella, E. Crocetti, S. Bianchi, V. Vezzosi, C. Urso, M. Biancalani, and M. Zappa Female breast cancer status according to ER, PR and HER2 expression: a population based analysis Pathol Oncol Res 17 3 September 2011 753 758
26. M. Zarcone, R. Amodio, I. Campisi, R. Cusimano, C. Dolcemascolo, V. Miceli, A. Traina, and M. Macaluso Application of a new classification to a breast tumor series from a population-based cancer registry: demographic, clinical, and prognostic features of incident cases, Palermo Province, 2002-2004 Ann N Y Acad Sci 1155 February 2009 222 226
27. M.L. Kwan, L.H. Kushi, E. Weltzien, B. Maring, S.E. Kutner, R.S. Fulton, M.M. Lee, C.B. Ambrosone, and B.J. Caan Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors Breast Cancer Res 11 3 2009 R31
28. M.E. Hammond, D.F. Hayes, A.C. Wolff, P.B. Mangu, and S. Temin American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer J Oncol Pract 6 4 July 2010 195 197
29. R. Haque, S.A. Ahmed, G. Inzhakova, J. Shi, C. Avila, J. Polikoff, L. Bernstein, S.M. Enger, and M.F. Press Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades Cancer Epidemiol Biomarkers Prev 21 10 October 2012 1848 1855